Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests best method to save Kids' decayed baby teeth

NCT ID NCT07333872

Disease control Sponsor: Delta University for Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three dental procedures—pulpotomy, partial pulpotomy, and direct pulp capping—all using a material called MTA, to treat deep cavities in children's baby molars. The goal is to see which technique best preserves the tooth, prevents pain, and avoids infection. The trial involves 96 healthy children aged 4-7 years with reversible pulpitis, and will track outcomes like pain, X-ray changes, and signs of infection.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mineral trioxide aggregate (MTA)
What this could lead to
If successful, this could show which technique best preserves baby teeth and avoids pain or infection, guiding dentists toward simpler, more effective treatments.
What could go wrong
This is a small, early-stage study with only 96 children, and results may not apply to all kids or teeth. There is also a risk that the treated tooth may still need extraction later.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

96 people

The number who actually took part.

Started

Jun 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

4 to 7 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * articipants were cooperative children (4-7 years) with no systemic diseases or relevant allergies. Eligible teeth were restorable primary second molars with deep carious lesions and a diagnosis of reversible pulpitis, Exclusion Criteria: * spontaneous pain, edema, fistula, pathological mobility, or percussion sensitivity.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Reversible pulpitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pulpitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Vital pulp therapy in primary teeth

Contacts and locations

Locations

  • Delta university for science and technology

    Gamasa, Dakahlia Governorate, 35516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.